Foghorn Therapeutics Inc. Revenue Breakdown
No Revenue Breakdown for FHTX on this site yet.
- 2025-12-31: Others Not split by product in the filing$30.91M100.00%; Total revenue $30.91M.
- 2024-12-31: Others Not split by product in the filing$22.60M100.00%; Total revenue $22.60M.
- 2023-12-31: Others Not split by product in the filing$34.16M100.00%; Total revenue $34.16M.
- 2022-12-31: Others Not split by product in the filing$19.23M100.00%; Total revenue $19.23M.
Source checked: the stored Revenue Breakdown page for FHTX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $30.91M 100.00% | $30.91M |
| 2024-12-31 | Not split by product in the filing $22.60M 100.00% | $22.60M |
| 2023-12-31 | Not split by product in the filing $34.16M 100.00% | $34.16M |
| 2022-12-31 | Not split by product in the filing $19.23M 100.00% | $19.23M |
| 2021-12-31 | Not split by product in the filing $1.32M 100.00% | $1.32M |
| 2020-12-31 | $430.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $16.07M 100.00% | $16.07M |
| 2026-03-31 | Not split by product $3.27M 100.00% | $3.27M |
| 2025-12-31 | Not split by product $9.25M 100.00% | $9.25M |
| 2025-09-30 | Not split by product $8.15M 100.00% | $8.15M |
| 2025-06-30 | Not split by product $7.56M 100.00% | $7.56M |
| 2025-03-31 | Not split by product $5.95M 100.00% | $5.95M |
| 2024-12-31 | Not split by product $2.86M 100.00% | $2.86M |
| 2024-09-30 | Not split by product $7.81M 100.00% | $7.81M |
| 2024-06-30 | Not split by product $6.89M 100.00% | $6.89M |
| 2024-03-31 | Not split by product $5.05M 100.00% | $5.05M |
| 2023-12-31 | Not split by product $5.77M 100.00% | $5.77M |
| 2023-09-30 | Not split by product $17.48M 100.00% | $17.48M |
| 2023-06-30 | Not split by product $5.60M 100.00% | $5.60M |
| 2023-03-31 | Not split by product $5.31M 100.00% | $5.31M |
| 2022-12-31 | Not split by product $4.18M 100.00% | $4.18M |
| 2022-09-30 | Not split by product $6.63M 100.00% | $6.63M |
| 2022-06-30 | Not split by product $4.49M 100.00% | $4.49M |
| 2022-03-31 | Not split by product $3.92M 100.00% | $3.92M |
| 2021-12-31 | Not split by product $713.00K 100.00% | $713.00K |
| 2021-09-30 | Not split by product $41.00K 100.00% | $41.00K |
| 2021-06-30 | Not split by product $279.00K 100.00% | $279.00K |
| 2021-03-31 | Not split by product $286.00K 100.00% | $286.00K |
| 2020-12-31 | Not split by product $251.00K 100.00% | $251.00K |
| 2020-09-30 | Not split by product $179.00K 100.00% | $179.00K |
| 2020-06-30 | Not split by product $0.00 | $0.00 |
| 2020-03-31 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |